The systemic status of redox (reduction/oxidation) in glaucoma has been the subject of increasing interest following identification of the circulating autoantibodies against antioxidative stress enzymes and chaperone molecules glutathione S-transferase [11] and heat shock proteins [12,13] in the serum of patients with glaucoma. The gene discussed is HPGDS; the disease is glaucoma.